Ritter Ira E. 4
4 · RITTER PHARMACEUTICALS INC · Filed Oct 27, 2017
Insider Transaction Report
Form 4
Ritter Ira E.
DirectorExec. Chairman, CSO
Transactions
- Purchase
Common Stock
2017-10-03+187,500→ 1,004,772 total(indirect: By LLC) - Purchase
Warrants (right to buy)
2017-10-03+187,500→ 187,500 total(indirect: By LLC)Exercise: $0.44From: 2017-10-03Exp: 2022-10-03→ Common Stock (187,500 underlying)
Holdings
- 6,250(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Stonehenge Partners LLC ("Stonehenge") purchased 187,500 Class A Units of the Issuer, consisting of 187,500 shares of common stock and warrants to purchase 187,500 shares of common stock, in the Issuer's October 2017 public offering at the public offering price of $0.40 per Class A Unit. The shares of common stock and warrants that are part of the Class A Units sold to Stonehenge in the puble offering were immediately separable and were issued separately in the offering.
- [F2]As a managing partner of Stonehenge the Reporting Person may be deemed the beneficial owner of these shares. The Reporting Person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
- [F3]These shares are held in a retirement plan trust of which the Reporting Person and his spouse are trustees. The Reporting Person's spouse and the revocable trust of the Reporting Person and his spouse are beneficiaries of the retirement plan trust. The Reporting Person expressly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.